Speaker illustration

Miss Tamar de Vries

University Medical Center Utrecht, Utrecht (Netherlands (The))

Heterogeneity of treatment effects from an intensive lifestyle weight loss intervention on cardiovascular events in patients with type 2 diabetes: data from the Look AHEAD trial.

Event: ESC CONGRESS 2019

Topic: Diabetes and the Heart

Session: Diabetes and the heart

Thumbnail

Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial

Event: ESC CONGRESS 2019

Topic: Secondary Prevention

Session: Young Investigator Award Session Thrombosis

Thumbnail

Estimating individual cardiovascular disease risk reduction by blood pressure lowering in elderly patients: results from the HYVET study

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Hypertension - Risk profiling and treatment

Thumbnail

ESC 365 is supported by

logo Novo Nordisk